Reports
Reports
Analysts’ Viewpoint on Respiratory Monitoring Devices Market Scenario
The global respiratory monitoring devices market has grown exponentially during the COVID-19 outbreak. COVID-19 can cause major respiratory issues among patients. This has increased the usage of respiratory monitoring devices in health care facilities and home care. Increase in government expenditure on health care in emerging economies such as India and rise in prevalence of respiratory disorders are likely to augment the global market during the forecast period. Product innovations and technological advancements are also projected to drive the global respiratory monitoring devices market in the next few years. Overall, respiratory monitoring devices will continue to be important due to increasing respiratory diseases and changing pollution levels.
Monitoring refers to evaluation of the physiologic function of a patient. It assists the health care provider in making clinical decisions and determining the line of treatment. It is also used to determine the patient’s response to clinical interventions. Respiratory monitoring devices, such as smart pulse oximeters and spirometers, help in monitoring patients’ respiratory condition. Respiratory monitoring plays a significant role in the management of patients with respiratory diseases such as acute respiratory failure, chronic obstructive pulmonary disease (COPD), and asthma. A number of technologically advanced respiratory monitoring devices are available in the market for personal use, intensive care, and in-patient settings.
The global respiratory monitoring devices market is anticipated to grow at a rapid pace during the forecast period owing to the rise in prevalence of respiratory diseases, such as asthma, cystic fibrosis, and COPD, and increase in geriatric population.
Prevalence of respiratory diseases such as asthma, cystic fibrosis, and COPD is rising across the globe. Patients suffering from severe COPD require continuous supply of oxygen. Often, symptoms such as increase in breathlessness and coughing are ignored as a common sign of aging; however, these can be early signs of COPD.
Globally, around 65 million individuals struggle with COPD. Sleep apnea is a partial or complete collapse of the upper airway. It is caused by relaxation of muscles that control the soft palate and the tongue. In 2019, around 25 million people had obstructive sleep apnea disorder globally. Prevalence of sleep apnea is similar to that of asthma and diabetes in the U.S. This is driving the demand for respiratory monitoring devices.
Life expectancy of people has increased in the last decade. This has led to a rise in population pool in the above reproducible age group. The immune system of a person weakens with age. Hence, surge in geriatric population increases the risk of contracting diseases in this age group. The number of elderly people in less developed countries is projected to rise more than 250% between 2010 and 2050 compared to 71% in developed countries. Aging increases the risk of contracting respiratory diseases. This is expected to boost the demand for therapeutic respiratory devices during the forecast period.
In terms of product, the global market has been classified into pulse oximeters, capnographs, spirometers, polysomnographs (PSG), peak flow meters, gas analyzers, and others. The pulse oximeters segment dominated the market in 2021, with around 37% share. The trend is anticipated to continue during the forecast period. Technical advancements in pulse oximeters and increase in demand for non-invasive respiratory monitoring devices and painless tests for measuring oxygen saturation level are likely to augment the pulse oximeter segment during the forecast period.
In terms of end-user, the global respiratory monitoring device market has been divided into home care, hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment held major share of around 39% in 2021. This trend is projected to continue during the forecast period. Growth of the segment can be ascribed to the easy availability of respiratory devices in hospitals, increase in patient population, and rise in demand for respiratory monitoring devices.
North America accounted for the largest share of around 36% of the global respiratory monitoring devices market in 2021. This can be ascribed to product approvals by the Food and Drug Administration (FDA) and presence of well-established companies that offer respiratory care devices. Europe held around 31% share of the global market in 2021. The market in the region in likely to grow at a rapid pace during the forecast period due to the rise in focus on respiratory care management in home care setting. Asia Pacific held larger share of the global market in 2021 than Latin America and Middle East & Africa. However, the market in Latin America is projected to grow at a faster rate from 2022 to 2031 than that in Middle East & Africa.
The respiratory monitoring devices market report concludes with the company profiles section, which includes key information about major players in the global market. Key players are engaged in product innovations and technological advancements to increase their share and strengthen their position in the global market. Leading players in the respiratory monitoring devices market are Medtronic, Philips Healthcare (Koninklijke Philips N.V.), Smiths Medical (Smiths Group plc), Drägerwerk AG & Co. KGaA, GE Healthcare (General Electric Company), Welch Allyn, Inc. (Hill-Rom Holdings, Inc.), Masimo, MGC Diagnostics Corporation, Vyaire Medical, Inc. (Becton, Dickinson and Company and Apax Partners’ Joint Venture), Nihon Kohden Corporation, and Novelda AS.
Each of these players has been profiled in the respiratory monitoring devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size Value in 2021 | US$ 7.7 Bn |
| Market Forecast Value in 2031 | More than US$ 15 Bn |
| Growth Rate (CAGR) | 6.3% |
| Forecast Period | 2022-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global respiratory monitoring devices market was valued at US$ 7.7 Bn in 2021.
The global respiratory monitoring devices market is projected to reach more than US$ 15 Bn by 2031.
The global respiratory monitoring devices market is anticipated to grow at a CAGR of 6.3% from 2022 to 2031.
The pulse oximeters segment held over 37% share of the global respiratory monitoring devices market in 2021.
North America is expected to account for the major share of the global respiratory monitoring devices market during the forecast period.
Medtronic, Philips Healthcare (Koninklijke Philips N.V.), Smiths Medical (part of Smiths Group plc), Dragerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), and Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Respiratory Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Respiratory Monitoring Devices Market Analysis and Forecast, 2017-2027
5. Key Insights
5.1. Technological Advancements
5.2. Prevalence of Asthma & COPD by Region/Country
5.3. Annual Cost of COPD and Asthma
5.4. Key Industry Events (Mergers, Acquisitions, Collaborations, Launch & Approvals, etc.)
5.5. Reimbursement Scenario
5.6. Overview of respiratory disease monitoring in homecare settings
6. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
6.2.1. Pulse Oximeters
6.2.2. Capnographs
6.2.3. Spirometers
6.2.4. Polysomnographs (PSG)
6.2.5. Peak Flow Meters
6.2.6. Gas Analyzers
6.2.7. Others
6.3. Global Respiratory Monitoring Devices Market Attractiveness, by Product
7. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by End-user
7.1. Introduction
7.2. Global Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
7.2.1. Home Care
7.2.2. Hospitals
7.2.3. Ambulatory Surgical Centers
7.2.4. Specialty Clinics
7.3. Global Respiratory Monitoring Devices Market Attractiveness, by End-user
8. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Region
8.1. Introduction
8.2. Global Respiratory Monitoring Devices Market Value Forecast, by Region, 2017-2027
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Respiratory Monitoring Devices Market Attractiveness, by Region
9. North America Respiratory Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.2. North America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
9.2.1. Pulse Oximeters
9.2.2. Capnographs
9.2.3. Spirometers
9.2.4. Polysomnographs (PSG)
9.2.5. Peak Flow Meters
9.2.6. Gas Analyzers
9.2.7. Others
9.3. North America Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
9.3.1. Home Care
9.3.2. Hospitals
9.3.3. Ambulatory Surgical Centers
9.3.4. Specialty Clinics
9.4. North America Respiratory Monitoring Devices Market Value Forecast, by Country, 2017-2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Respiratory Monitoring Devices Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Respiratory Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.2. Europe Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
10.2.1. Pulse Oximeters
10.2.2. Capnographs
10.2.3. Spirometers
10.2.4. Polysomnographs (PSG)
10.2.5. Peak Flow Meters
10.2.6. Gas Analyzers
10.2.7. Others
10.3. Europe Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
10.3.1. Home Care
10.3.2. Hospitals
10.3.3. Ambulatory Surgical Centers
10.3.4. Specialty Clinics
10.4. Europe Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017-2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Respiratory Monitoring Devices Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Respiratory Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
11.2.1. Pulse Oximeters
11.2.2. Capnographs
11.2.3. Spirometers
11.2.4. Polysomnographs (PSG)
11.2.5. Peak Flow Meters
11.2.6. Gas Analyzers
11.2.7. Others
11.3. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
11.3.1. Home Care
11.3.2. Hospitals
11.3.3. Ambulatory Surgical Centers
11.3.4. Specialty Clinics
11.4. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017-2027
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Respiratory Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
12.2.1. Pulse Oximeters
12.2.2. Capnographs
12.2.3. Spirometers
12.2.4. Polysomnographs (PSG)
12.2.5. Peak Flow Meters
12.2.6. Gas Analyzers
12.2.7. Others
12.3. Latin America Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
12.3.1. Home Care
12.3.2. Hospitals
12.3.3. Ambulatory Surgical Centers
12.3.4. Specialty Clinics
12.4. Latin America Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017-2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Respiratory Monitoring Devices Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Respiratory Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
13.2.1. Pulse Oximeters
13.2.2. Capnographs
13.2.3. Spirometers
13.2.4. Polysomnographs (PSG)
13.2.5. Peak Flow Meters
13.2.6. Gas Analyzers
13.2.7. Others
13.3. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
13.3.1. Home Care
13.3.2. Hospitals
13.3.3. Ambulatory Surgical Centers
13.3.4. Specialty Clinics
13.3.5. Hospitals
13.4. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017-2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Global Respiratory Monitoring Devices Market Share Analysis, by Company, 2021
14.2. Company Profiles
14.2.1. Medtronic
14.2.1.1. Company Description
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Philips Healthcare (Koninklijke Philips N.V.)
14.2.2.1. Company Description
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. Smiths Medical (part of Smiths Group plc)
14.2.3.1. Company Description
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Dragerwerk AG & Co. KGaA
14.2.4.1. Company Description
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. GE Healthcare (part of General Electric Company)
14.2.5.1. Company Description
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)
14.2.6.1. Company Description
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Masimo
14.2.7.1. Company Description
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. MGC Diagnostics Corporation
14.2.8.1. Company Description
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. Vyaire Medical Inc. (Becton, Dickinson and Company and Apax Partners’ Joint Venture)
14.2.9.1. Company Description
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. Nihon Kohden Corporation
14.2.10.1. Company Description
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
14.2.11. Novelda AS
14.2.11.1. Company Description
14.2.11.2. Business Overview
14.2.11.3. Financial Overview
14.2.11.4. Strategic Overview
14.2.11.5. SWOT Analysis
List of Tables
Table 01: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 03: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 06: North America Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 09: Europe Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Asia Pacific Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 12: Asia Pacific Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Latin America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Latin America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Latin America Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Middle East and Africa Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East and Africa Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 18: Middle East and Africa Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Respiratory Monitoring Devices market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Respiratory Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 03: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031
Figure 04: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
Figure 05: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Pulse Oximeters, 2017-2031
Figure 06: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Peak Flow Meters, 2017-2031
Figure 07: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Capnographs, 2017-2031
Figure 08: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, Spirometers, 2017-2031
Figure 09: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Polysomnographs (PSG), 2017-2031
Figure 10: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Gas Analyzers, 2017-2031
Figure 11: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Others, 2017-2031
Figure 12: Global Respiratory Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 13: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031
Figure 14: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031
Figure 15: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Ambulatory Surgical Centers, 2017-2031
Figure 16: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Specialty Clinics, 2017-2031
Figure 17: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Home Care, 2017-2031
Figure 18: Global Respiratory Monitoring Devices Market Value Share Analysis, by Region, 2021 and 2031
Figure 19: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by Region, 2022-2031
Figure 20: North America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 21: North America Respiratory Monitoring Devices Market Value Share Analysis, by Country, 2021 and 2031
Figure 22: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by Country, 2022-2031
Figure 23: North America Respiratory Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 24: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031
Figure 25: North America Respiratory Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 26: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031
Figure 27: Europe Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 28: Europe Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 29: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 30: Europe Respiratory Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 31: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031
Figure 32: Europe Respiratory Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 33: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031
Figure 34: Asia Pacific Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 35: Asia Pacific Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 36: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 37: Asia Pacific Respiratory Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 38: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031
Figure 39: Asia Pacific Respiratory Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 40: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031
Figure 41: Latin America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 42: Latin America Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 43: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 44: Latin America Respiratory Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 45: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031
Figure 46: Latin America Respiratory Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 47: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031
Figure 48: Middle East and Africa Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 49: Middle East and Africa Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 50: Middle East and Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 51: Middle East and Africa Respiratory Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 52: Middle East and Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031
Figure 53: Middle East and Africa Respiratory Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 54: Middle East and Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Respiratory Monitoring Devices Market